Issue 4, 2015

Label-free detection of Alzheimer’s disease through the ADP3 peptoid recognizing the serum amyloid-beta42 peptide

Abstract

The early diagnosis of Alzheimer’s disease (AD) is challenging due to the lack of reliable methods for detecting its biomarkers in the noninvasive biopsies. We used surface plasmon resonance imaging to identify AD based on the detection of amyloid-beta42 in the serum by the ADP3 peptoid.

Graphical abstract: Label-free detection of Alzheimer’s disease through the ADP3 peptoid recognizing the serum amyloid-beta42 peptide

Supplementary files

Article information

Article type
Communication
Submitted
06 Sep 2014
Accepted
18 Nov 2014
First published
18 Nov 2014

Chem. Commun., 2015,51, 718-721

Author version available

Label-free detection of Alzheimer’s disease through the ADP3 peptoid recognizing the serum amyloid-beta42 peptide

Z. Zhao, L. Zhu, X. Bu, H. Ma, S. Yang, Y. Yang and Z. Hu, Chem. Commun., 2015, 51, 718 DOI: 10.1039/C4CC07037B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements